Kathmandu, June 8 (IANS) Coronil, the so-called immunity booster kit manufactured by yoga guru Ramdevs Patanjali group in India, has landed in a controversy in Nepal after the Himalayan nations Department of Ayurveda and Alternative Medicine imposed a ban on its distribution.The Health Ministry of Nepal, however, has remained silent over the ongoing controversy regarding the distribution of Coronil kits, which have also landed in controversy in India and Bhutan. The controversy erupted in Nepal after the Patanjai Yoghpeeth on last Thursday handed over Coronil kits, sanitisers, masks and other immunity booster medicines worth crores of rupees to outgoing Health Minister, Hrydesh Tripathi. The day after he received the support from local officials of the Patanjali Yogpeeth Nepal, Tripathi was removed as the Health Minister. "The Coronil kits provided by the Patanjali Yogpeeth did not receive permission from the Department of Drug Administration, so we have decided not to distribute it," Basudev Upadhyay, the Director General of the Department of Ayurveda and Alternative Medicine, said in a press conference. "The Coronil kit could be beneficial for the treatment of respiratory disorders, but it has not taken permission from the Department of Drug Administration, so we cannot distribute it," Upadhyay added.As per the Nepali law, any drug can be imported only after obtaining permission from the DDA.Meanwhile, the spokesperson at Nepal's Health Ministry, Krishna Poudel, told IANS that he is not aware about the distribution of Coronil kits in Nepal. "We do not know if the outgoing Health Minister Tripathi accepted the support. We have heard that it is yet to get permission from the DDA," said Poudel."Coronil is not registered with the DDA and it cannot be distributed or sold out without registration," DDA spokesperson Santosh K.C. told IANS. "We have not received any document for its registration as well as seeking permission for selling out in Nepal. We do not know how the former Health Minister accepted the donation. We have not received any letter from the Health Ministry to grant permission for its distribution," he said. Meanwhile, Patanjai Yogpeeth said that the consignment of 1,500 Coronil kits was provided upon the request from the government of Nepal.Officials at Nepal's Health Ministry said that officials from Patanjali Yogpeeth in Nepal and India had approached former Health Minister Tripathi directly, handing over some documents that received permission from the government of India for its distribution and provision of selling for the general public as an immunity booster. The Bhutan government had already rejected the support provided by Patanjali.--IANSstr/arm
इंडियन मेडिकल एसोसिएशन (आईएमए) ने पतंजलि के कोरोनिल का समर्थन करने के लिए सोमवार को केंद्रीय स्वास्थ्य मंत्री हर्षवर्धन को आड़े हाथों लिया। कोरोनिल को कोविड-19 के उपचार के उद्देश्य से दोबारा लांच किया गया था, हालांकि विश्व स्वास्थ्य संगठन (डब्ल्यूएचओ) ने पतंजलि के इस दावे पर सवाल उठाया है। आईएमए ने कहा कि मेडिकल काउंसिल ऑफ इंडिया की संहिता के अनुसार, जो हर आधुनिक मेडिकल डॉक्टर के लिए बाध्यकारी है, कोई भी डॉक्टर किसी भी दवा को प्रमोट नहीं कर सकता है। हालांकि, यह आश्चर्य की बात है कि स्वास्थ्य मंत्री, जो खुद एक आधुनिक चिकित्सा डॉक्टर हैं, दवा का प्रचार करते हुए पाए गए।
आईएमए ने कहा कि देश के स्वास्थ्य मंत्री की उपस्थिति में बनाई गई एक अवैज्ञानिक दवा का गलत और मनगढ़ंत प्रक्षेपण, जिसे बाद में डब्ल्यूएचओ ने खारिज कर दिया, पूरे देश का अपमान है।
एसोसिएशन ने योगगुरु रामदेव द्वारा संचालित आयुर्वेदिक दवा फर्म पतंजलि के एक कार्यक्रम में एक चिकित्सक व स्वास्थ्य मंत्री के रूप में उपस्थिति के लिए केंद्रीय स्वास्थ्य मंत्री की नैतिकता पर सवाल उठाया।
एसोसिएशन ने राष्ट्रीय चिकित्सा आयोग (तत्कालीन एमसीआई) के तहत एक अनुच्छेद का उल्लेख किया जो एक चिकित्सक को किसी दवा को प्रमोट करने की अनुमति नहीं देता है।
आईएमए ने कहा कि धारा 6: 1: 1 के तहत, कोई डॉक्टर किसी भी व्यक्ति को किसी दवा के संबंध में अनुमोदन, सिफारिश, समर्थन, प्रमाण पत्र, रिपोर्ट या बयान अपने नाम, हस्ताक्षर के साथ नहीं दे सकता है, चाहे वह मुआवजे के लिए हो या किसी अन्य उद्देश्य के लिए।
एसोसिएशन ने कहा कि वह "मेडिकल काउंसिल ऑफ इंडिया के आचार संहिता के प्रति असम्मान" पर स्वत: संज्ञान लेने एवं हर्षवर्धन से स्पष्टीकरण मांगने के लिए एनएमसी को पत्र लिखेंगे।
गौरतलब है कि 19 फरवरी को आयोजित एक कार्यक्रम में, जहां हर्षवर्धन और केंद्रीय परिवहन मंत्री नितिन गडकरी भी मौजूद थे, पतंजलि ने कोरोनिल टैबलेट को "कोविड-19 के लिए पहली साक्ष्य-आधारित दवा" बताया था।
इस कार्यक्रम में आयुर्वेदिक फर्म के सह-संस्थापक बाबा रामदेव ने दावा किया था कि आयुर्वेदिक दवा को विश्व स्वास्थ्य संगठन (डब्ल्यूएचओ) से प्रमाणन मिला है, जिसे बाद में संयुक्त राष्ट्र के एक आधिकारिक ट्वीट में इनकार कर दिया गया था।
The Indian Medical Association (IMA) on Monday came down heavily on Union Health Minister Harsh Vardhan for endorsing Patanjali's Coronil which was relaunched as treatment of Covid-19, a claim questioned by the World Health Organisation.
"As per the code of the Medical Council of India, which binds the code of conduct of every modern medical doctor, no doctor can promote any drug. However, it is surprising that the health minister, who himself is a modern medicine doctor, was found promoting the drug," the association said.
The IMA said that the false and fabricated projection of an unscientific medicine made in the presence of the country's health minister, later rejected by the WHO is a slap and insult to the whole nation.
The association questioned the Union Health Minister's ethics as a physician and health minister of the country for making an appearance at the launch event organized by Ayurvedic drug firm Patanjali run by Yogaguru Ramdev.
The association mentioned a clause under the National Medical commission (erstwhile MCI) which prohibits a physician from promoting a drug.
"Under section 6:1:1, a physician shall not give to any person, whether for compensation or otherwise, any approval, recommendation, endorsement, certificate, report or statement with respect of any drug, medicine, with his name, signature, or photograph in any form or manner of advertising through any mode nor shall he boast of cases, operations, cures or remedies or permit the publication of report thereof through any mode," the IMA specified.
The associations said that it will write to the NMC for seeking suo moto explanation for Harsh Vardhan's "blatant disrespect to the code of conduct of Medical council of India".
In a grand launch event held on February 19, where Harsh Vardhan and Union Transport Minister Nitin Gadkari were also present, Patanjali had billed Coronil tablets as the "first evidence-based medicine for COVID-19".
In the event, Baba Ramdev, co-founder of the ayurvedic firm had claimed that the ayurvedic medicine has received certification from the World Health Organization (WHO), which was later denied by the UN body in an official tweet.
At the launch event of Coronil, Patanjali said, "Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme."
Hours later, the WHO South-East Asia tweeted: "WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment of COVID-19".
Now when the WHO rejected the claims, Patanjali's CEO Acharya Balkrishna made a clarification on Twitter. He wrote: "We want to clarify to avoid confusion that our WHO GMP compliant COPP certificate to Coronil is issued by DCGI, Government of India".
Balkrishna also added that "WHO does not approve or disapprove of any drugs. Instead, it works for building a better and healthier future for people all over the world". (Agency)
New Delhi- Ramdev, yoga guru and co-founder of Patanjali, on Friday released a scientific research paper prepared by the Patanjali Research Institute on the "first evidence-based ayurvedic medicine" against coronavirus named Coronil.
The paper was launched in the presence of Union ministers Harsh Vardhan and Nitin Gadkari at an event organised by Patanjali.
"Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme," Patanjali said in a statement.
Under CoPP, Coronil can now be exported to 158 countries.
"Amid the global struggle to make Covid-19 vaccine, Patanjali Research Institute has accomplished to bring the first evidence based corona medicine through India's ancient medical system Ayurveda," the company added.
Commenting on the development, Ramdev said the drug will help the humanity while providing affordable treatment based on naturopathy. "On the basis of presented data, the Ministry of Ayush has recognised the Coronil tablet as a medicine for supporting measures in Covid-19," he informed.
The drug was first introduced by Patanjali in June 2020 with a claim to counter Covid-19, but ended up changing its label use to "immunity booster" after it failed to produce supporting evidence.
Coronil was under scrutiny earlier due to lack of scientific evidence and trials that could determine its efficacy in combating the deadly virus that has claimed more than 156,000 lives in the country. Coronil was first advertised as a cure for the coronavirus infection. However, when the controversy erupted over its trial data and composition, the firm changed its licenced use from cure for corona to immunity booster.
It had also received a notice from the Uttarakhand drug department. In its reply to the department, the firm clarified that it never claimed the drug to be a cure to coronavirus.
Ramdev said that the aim of the research was to accredit the ancient Indian medical science globally by providing scientific evidence and fulfilling the Aatmanirbhar Bharat vision in healthcare. While praising the efforts of modern medicine which aided the highest recovery rate and the lowest case fatality rate in the country, he said that due credit must be given to Ayurveda medicines and yogic lifestyle which also assisted in keeping the damaging parameters of Covid-19 disease low.
Meanwhile, Union Health Minister Harsh Vardhan emphasised the need of using modern scientific tools to highlight the importance of Ayurveda at the international level. "Patanjali under the leadership of Acharyaji and Swamiji will help Ayurveda get the recognition it deserves at the international level," he said.
The minister also cited the conversation between WHO Director General Tedros Adhanom Ghebreyesus with Prime Minister Narendra Modi. "The global body is impressed with India's work in the field and would want to establish a global centre for Ayurveda in India," he said..
The minister also noted that Ayurveda's economic contribution to the country has significantly increased after the pandemic.
"During the pre-Covid era, it (Ayurveda industry) used to contribute Rs 30,000 crore to the national economy with a growth rate of 15-20 per cent. This economy has risen by more than 50 per cent after the pandemic hit the world, with increased interest from FDIs as well," Harsh Vardhan said. (IANS)
Chennai, Aug 6 (IANS) Coming down heavily on yoga guru Ramdev's Patanjali Ayurved Ltd for "chasing profits by exploiting people's fear and panic" to sell its immunity booster tablet Coronil, the Madras High Court on Thursday slapped a penalty of Rs 10 lakh on it.The court also refused to vacate the interim injunction restraining Patanjali from using the name Coronil for its tablet in a trade mark infringement case.The case was filed by city-based company Arudra Engineers Private Ltd that had registered the trademarks "Coronil-92 B and Coronil-213 SPL" in 1993 and holds rights over them till 2027.The company sells an anti-corrosion product - a chemical agent that undertakes to sanitise and clean heavy industrial machinery and containment units at factories.Apart from Patanjali, the other defendant in the case was Divya Yog Mandir Trust that makes the tablet.The court order came in the petition filed by Patanjali and Divya Yog to vacate the interim injunction against the use of the name Coronil for its tablet.The court said: "Insofar as costs are concerned, the defendants have repeatedly projected that they are Rs 10,000 crore company. However, they are still chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the coronavirus, when actually their 'Coronil Tablet' is not a cure but rather an immunity booster for cough, cold and fever.""The defendants must realize that there are organisations which are helping the people in this critical period without seeking recognition and it would only be appropriate that they are made to pay costs to them," it ruled.The court ordered Patanjali and Divya Yog to pay jointly Rs 5 lakh each to the Dean, Adyar Cancer Institute, Chennai and to the Dean, Government Yoga and Naturopathy Medical College & Hospital, Chennai.In both the organisations, treatment are accorded free of cost without any claim to either trademark, trade name, patent or design, but only with service as a motto, the court said."Costs to be paid on or before 21.08.2020, and a memo in this regard, to be filed before the Registry, High Court Madras, on or before 25.08.2020," it ordered.--IANSvj/vd
New Delhi, July 15 (IANS) The Delhi Police on Wednesday told a district court that an FIR could not be registered against Patanjali Ayurved Limited, Ramdev and others on the charge of cheating people by claiming a cure for Covid-19 due to jurisdictional and other issues.The Vasant Vihar police station SHO said this in an action-taken report filed in the court in response to a plea that sought court directions to register a case against Ramdev and others.Petitioner Tushar Anand had claimed that Ramdev and other persons "only had permission to make an immunity booster but they are making a false claim in the media that they have found a cure for Covid-19".In the report, Sub-Inspector Pankaj Kumar said: "As the alleged press conference by Baba Ramdev was organised at Haridwar in Uttarakhand, the same does not lie within the area or jurisdiction of Vasant Vihar police station, New Delhi. Hence, no action can be initiated by police of Vasant Vihar PS."It further submitted that an FIR under Section 420 of the Indian Penal Code has already been registered at police station in Jyoti Nagar in Jaipur on the same grounds as levelled by the applicant in his complaint, refusing to register his complaint."It is also pertinent to mention here that the Ayush Ministry has allowed the sale of Patanjali's 'Coronil' as an immunity booster and not as a coronavirus cure. If there are allegations of violation of the guidelines of the Ayush Ministry, the complainant may approach the agency concerned," the status report added.The applicant had sought lodging of the FIR under Sections 270 (malignant act likely to spread infection of disease dangerous), 420 (cheating) and 504 (intentionally insults with intent to provoke break of public peace) of the IPC and the Drugs and Cosmetics Act and Drugs and Magic Remedies Act in the matter."The accused have shown their mala-fide intentions, which are likely to spread infection that is dangerous to life by misrepresenting and alluring innocent consumers to buy the medicine with a belief of getting cured from the deadly Covid-19," the petitioner had averred.On June 23, Patanjali Ayurved launched 'Coronil' tablet and Swasari Vati medicine with the claim that these could cure Covid-19 within seven days. On July 1, the Ayush Ministry permitted Patanjali to sell Coronil as long as it was advertised as an immunity booster, and not a 'coronavirus cure'.--IANSaka/tsb